J1570 HCPCS Level II Code: Injection, ganciclovir sodium, 500 mg
Coding at a Glance
- Drug products
- 8 NDC products
Medicare Coverage & Payment
- CMS short descriptor: Ganciclovir sodium injection
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 1997
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- January 1, 1994Added to the code setInjection, ganciclovir sodium, 500 mg
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q3
Medicare Part B payment limit (ASP + 6%): $31.46
25021-0185-10 Ganciclovir — Sagent Pharmaceuticals (size 1 × qty 25 (500 MG per billing unit))
25021-0185-11 Ganciclovir — Sagent Pharmaceuticals (size 10 × qty 1 (500 MG per billing unit))
42023-0173-25 Ganciclovir — Endo USA, Inc. (size 1 × qty 25 (500 MG per billing unit))
63323-0315-10 Cytovene — FreseniUS Kabi USA, LLC (size 1 × qty 25 (500 MG per billing unit))
63323-0315-94 Ganciclovir — FreseniUS Kabi USA, LLC (size 1 × qty 25 (500 MG per billing unit))
70436-0089-55 Ganciclovir — Slate Run Pharmaceuticals (size 1 × qty 25 (500 MG per billing unit))
70436-0231-55 Ganciclovir — Slate Run Pharmaceuticals (size 1 × qty 25 (500 MG per billing unit))
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J1570 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (29)
- J1551 — Injection, immune globulin (cutaquig), 100 mg[Sibling]
- J1552 — Injection, immune globulin (alyglo), 500 mg[Sibling]
- J1553 — Injection, immune globulin (yimmugo), 100 mg[Sibling]
- J1554 — Injection, immune globulin (asceniv), 500 mg[Sibling]
- J1555 — Injection, immune globulin (cuvitru), 100 mg[Sibling]
- J1556 — Injection, immune globulin (bivigam), 500 mg[Sibling]
- J1557 — Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg[Sibling]
- J1558 — Injection, immune globulin (xembify), 100 mg[Sibling]
- and 21 more
Change history
- January 1, 1994 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J1570 in its code family, with their registry titles.
- J1561 — Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562 — Injection, immune globulin (vivaglobin), 100 mg
- J1566 — Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
- J1568 — Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1569 — Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1571 — Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
- J1572 — Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1573 — Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
- J1574 — Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg
- J1575 — Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin